Study Stopped
Because of COVID pandemic
Analgesic Effects of Ultrasound-guided Dry-Needling Therapy for Neck and Head Pain
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The analgesic effects of ultrasound-guided dry-needling therapy will be evaluated in the management of head and neck pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 8, 2019
CompletedStudy Start
First participant enrolled
March 8, 2019
CompletedFirst Posted
Study publicly available on registry
March 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2023
CompletedDecember 3, 2024
November 1, 2024
4.8 years
March 8, 2019
November 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Trigger Point
The number of the elicited myofascial trigger points assessed during dry-needling treatment
The first hour of the treatment
Secondary Outcomes (5)
Analgesic request
3 months trom treatment
Karnofsky Performance Status
3 months from treatment
Range Of Motion (ROM)
3 months after treatment
Motion Related Pain
3 months after treatment
Perception
3 months after treatment
Study Arms (1)
Dry-Needling
EXPERIMENTALUltrasound-Guided Dry-Needling Therapy focused on the active and latent myofascial trigger points.
Interventions
The needle will be insert under ultrasound guidance to elicit the myofascial response on the neck of the patients
Eligibility Criteria
You may qualify if:
- Chronic neck pain
- Chronic head pain
You may not qualify if:
- previous surgery of neck and head
- Body Mass Index \> 39,99
- politrauma patients
- pregnancy
- neck and head infections
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
San Salvatore Academic Hospital
Coppito, L'Aquila, 67100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierfrancesco Fusco, MD
San Salvatore Academic Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 8, 2019
First Posted
March 11, 2019
Study Start
March 8, 2019
Primary Completion
December 25, 2023
Study Completion
December 25, 2023
Last Updated
December 3, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share